VideoBusiness Intelligence Center
You are here: Home : White Papers : Employee Benefits & Human Capital : Health Care : Abstract
Changing the Debate on Healthcare Costs in the US
Sponsored By GlaxoSmithKline
Free registration is required
- Abstract:
- The political response to rising costs tends to focus on the components of care cutting reimbursement, price controls, and limits on access for patients in public programs. Though chronic diseases are increasingly preventable and largely treatable, they account for the vast majority of healthcare spending. Little attention is directed at curbing healthcare costs by addressing chronic disease itself. To make a significant impact in both healthcare costs and the quality of care provided, reform efforts must focus on how to best limit the growth and burden of chronic disease.
- DETAILS
- Sponsored by:
-
- Released: April 24, 2009
- Length: 4 pages
- Format: PDF (438 kb)
- Email this abstract
- These white papers are not created by the CFO.com editorial staff. In order to view these papers, you must register with CFO.com and agree to share your contact information with related product/service companies.
Related White Papers in Health Care
Related White Papers in Defined Benefit
- A Qualified Commitment to DB Plans: Risk Management amid a Steep Downturn--A report prepared in collaboration with Towers Perrin
- How Should Institutional Investors View Hedge Funds Moving Forward
- Why CFOs Need More Funding Relief To Limit The Impact Of Pensions On Financial Statements
- Indications That Recent Hedge Fund Risks Have Declined
- Liability Driven Investing -- Three Reasons For Caution In Today's Implementation
advertisement
Inside CFO.com
- Top Story
- Start Your IFRS Engines?
- Most Recent Health Care Articles
- Benefits Costs Plague CFOs, Survey Finds
- Waiting and Wondering
- Aging Workforce: How to Fight the Risks
